# Xiaolei Wang

## Introduction

- Research Interests: XXX
- EMail: `wangxiaolei_wxl <at> buaa.edu.cn`

## Publication

- Jiale Cai, Guiping Hu, Lihua Hu, Junge Chen, Dan Chen, Dan Liu, **Xiaolei Wang**, Boxian Hu, Cheng Li. *A CaCO3-based nanoplatform with sonodynamic and tumor microenvironment activated for combined in vitro cancer therapy.* [Translational Oncology, 2023](https://doi.org/10.1016/j.tranon.2023.101771) [[PDF]](./tranon23.pdf) [JIF: 5]
- Jing Sun, Jingqi Fu, Yang Zhong, Lu Li, Chengjie Chen, **Xiaolei Wang**, Linlin Wang, Yongyong Hou, Huihui Wang, Rui Zhao, Xixuan Zhang, Masayuki Yamamoto, Yuanyuan Xu, Jingbo Pi. *NRF2 mitigates acute alcohol-induced hepatic and pancreatic injury in mice.* [Food and Chemical Toxicology, 2018](https://doi.org/10.1016/j.fct.2018.09.042) [[PDF]](./fct18.pdf) [JIF: 4.3]
- **Xiaolei Wang**, Hongxi Yu, Dan Liu, Boxian Hu, Ruihang Zhang, Lihua Hu, Guiping Hu, Cheng Li. *The application of nanomaterials in tumor therapy based on the regulation of mechanical properties.* [Nanoscale, 2024](http://dx.doi.org/10.1039/D4NR01812E) [[PDF]](./nanoscale24.pdf) [JIF: 5.8]
- Lihua Hu, Boxian Hu, Long Zhang, Yuhong Hu, Yali Zhang, Ruihang Zhang, Hongxi Yu, Dan Liu, **Xiaolei Wang**, Ouya Lin, Yanjun Gong, Yan Zhang, Cheng Li, Jianping Li. *Role of gut microbiota and metabolomics in the lipid-lowering efficacy of statins among Chinese patients with coronary heart disease and hypercholesterolemia.* [Frontiers in Cellular and Infection Microbiology, 2024](https://doi.org/10.3389/fcimb.2024.1408581) [[PDF]](./fcimb24.pdf) [JIF: 4.6]
